Jazz Pharma Drops Last Defendant From Epidiolex Patent Suit – Law360
Jazz Pharma Drops Last Defendant From Epidiolex Patent Suit Law360
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
Brendan O’Dea to Co-Host NYIPLA Discussion of “Avoiding Common Rejections in Design …
… Intellectual Property Law Association (NYIPLA) discussion on “Avoiding Common Rejections in Design Patent Applications” on Feb, 13th, 2025.
-
In: PATENT NEWS
Webinar: An Introduction to the Unitary Patent Court and Unitary Patents – IPWatchdog.com
Webinar: An Introduction to the Unitary Patent Court and Unitary Patents IPWatchdog.com
-
In: PATENT NEWS
Nokia gets patent injunction against Amazon in partial win in Germany – mlex.com
Nokia gets patent injunction against Amazon in partial win in Germany mlex.com
-
In: PATENT NEWS
Groupon Must Defend Patent Suit Over Online Incentive Technology – Bloomberg Law News
The Federal Circuit revived a lawsuit against Groupon Inc. by an owner of a patent on online incentive programs. Kroy IP Holdings, a company tied …
-
In: PATENT NEWS
Groupon Must Defend Patent Suit Over Online Incentive Technology – Bloomberg Law
Groupon Must Defend Patent Suit Over Online Incentive Technology Bloomberg Law
-
In: PATENT NEWS
Million-Dollar Mysteries: Recent Complex Patent Cases Lost to Rule 36
While some judges defend Rule 36 affirmances as appropriate for easy to see “losers,” an examination of these recent cases reveals sophisticated legal …
-
In: PATENT NEWS
Amgen Saves Patent For Making Parathyroid Drug – Law360
A board of appeal at the European Patent Office has held in newly public Dec. 17 decision that Amgen could keep exclusive rights over a method for …
-
In: PATENT NEWS
O’Melveny Secures Win for LG Electronics in Patent Case
Intellectual Property: Patent Law · Intellectual Property & Technology. Stay Connected. For the latest legal developments, analysis, and trends—plus a …
-
In: PATENT NEWS
Renewed Efforts in Congress for Pharmaceutical Patent Reform – JD Supra
S.150, otherwise known as the Affordable Prescriptions for Patients Act of 2023, proposed capping the number of patents a biologic manufacturer can …